Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAshmore Group Regulatory News (ASHM)

Share Price Information for Ashmore Group (ASHM)

Share Price is delayed by 15 minutes
Get Live Data
199.40    -3.20 (-1.58%)
Bid:
199.10
Ask:
199.70
Spread: 0.60 (0.301%)
Market Cap: £1.30b
ASHM Live PriceLast checked at - London Stock Exchange

Intraday Ashmore Group Share Chart

Trading Statement

16 Apr 2019 07:00

RNS Number : 2630W
Ashmore Group PLC
16 April 2019
Β 

Ashmore Group plc16 April 2019

THIRD QUARTER ASSETS UNDER MANAGEMENT STATEMENT

Ashmore Group plc ("Ashmore", "the Group"), the specialist Emerging Markets asset manager, announces the following update to its assets under management ("AuM") in respect of the quarter ended 31 March 2019.

Assets under management

Theme

Actual31 December 2018

(US$ billion)

Estimated31 March 2019

(US$ billion)

Movement

(%)

External debt

15.5

16.7

+7.7%

Local currency

17.5

19.1

+9.1%

Corporate debt

10.8

14.1

+30.6%

Blended debt

20.4

22.0

+7.8%

Equities

4.4

4.7

+6.8%

Alternatives

1.6

1.6

-

Multi-asset

0.4

0.5

+25.0%

Overlay / liquidity

6.1

6.6

+8.2%

Total

76.7

85.3

+11.2%

Β 

Assets under management increased by US$8.6 billion during the period, through net inflows of US$5.0 billion and positive investment performance of US$3.6 billion.

Client demand remains strong and broad-based across investment themes, with net inflows in the corporate debt, local currency, overlay/liquidity, blended debt and external debt investment themes. Institutional flows continue to be biased towards existing clients, including additional allocations to large mandates in the corporate debt and overlay/liquidity themes. There was ongoing momentum in mutual fund flows, particularly in Europe and the US, with continued interest in the short duration, local currency bond and blended debt strategies.

Absolute performance levels were highest in the blended debt and external debt themes, and despite US dollar strength in the latter part of the period, local currency and equities delivered good returns over the three months. Corporate debt and multi-asset also produced positive performance. Ashmore's relative investment performance remains strong over three and five years, and the consistent implementation of its investment processes means that one year performance versus benchmarks has, as expected, improved strongly over the quarter.

Mark Coombs, Chief Executive Officer, Ashmore Group plc, commented:

"Client activity levels picked up through the quarter following a slight pause at the end of 2018. This reflects a number of ongoing positive factors including investors' light positioning in Emerging Markets, the significant value available across a diverse range of investment themes, and slowing growth and political challenges in the developed world. The increasing diversity of Ashmore's product range enables flows to be captured at different points in the cycle. These factors, together with the delivery of strong performance across the investment themes, mean Ashmore is well-positioned for continued growth."

Β 

Ashmore's Legal Entity Identifier (LEI) is 549300U3L59WB4YI2X12.

Β 

For further information please contact:

Ashmore Group plcPaul MeasdayInvestor Relations +44 (0)20 3077 6278

FTI ConsultingNeil Doyle +44 (0)20 3727 1141Laura Ewart +44 (0)20 3727 1160

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Β 
END
Β 
Β 
TSTLLFSRSSIELIA
Date   Source Headline
28th May 202612:33 pmRNSDirector/PDMR Shareholding
16th Apr 20267:00 amRNSTrading Statement
1st Apr 202611:05 amRNSDirector/PDMR Shareholding
31st Mar 20267:00 amRNSAlliance
17th Mar 20263:36 pmRNSDirector/PDMR Shareholding
12th Feb 20264:25 pmRNSHolding(s) in Company
12th Feb 20267:00 amRNSHalf-year Financial Report
15th Jan 20267:00 amRNSTrading Statement
9th Dec 20252:12 pmRNSDirector/PDMR Shareholding
6th Nov 20252:34 pmRNSResult of AGM
14th Oct 20257:00 amRNSTrading Statement
9th Oct 20251:51 pmRNSHolding(s) in Company
25th Sep 20252:00 pmRNSNotice of AGM
19th Sep 20253:00 pmRNSDirector/PDMR Shareholding
19th Sep 20251:24 pmRNSDirector/PDMR Shareholding
18th Sep 202511:17 amRNSAnnual Financial Report
5th Sep 20257:00 amRNSFinal Results
14th Jul 20257:00 amRNSTrading Statement
11th Jul 20254:56 pmRNSHolding(s) in Company
30th Jun 20253:16 pmRNSDirectorate Change
23rd Jun 20252:20 pmRNSHolding(s) in Company
18th Jun 20255:18 pmRNSHolding(s) in Company
17th Jun 20254:15 pmRNSHolding(s) in Company
12th Jun 20259:36 amRNSHolding(s) in Company
10th Jun 20254:02 pmRNSHolding(s) in Company
6th Jun 20254:15 pmRNSHolding(s) in Company
6th Jun 202511:16 amRNSDirector/PDMR Shareholding
6th Jun 20259:00 amRNSHolding(s) in Company
4th Jun 20254:08 pmRNSHolding(s) in Company
27th May 20252:00 pmRNSHolding(s) in Company
14th Apr 20257:00 amRNSTrading Statement
7th Apr 20255:46 pmRNSDirector/PDMR Shareholding
31st Mar 20255:49 pmRNSDirector/PDMR Shareholding
18th Mar 202512:43 pmRNSDirector/PDMR Shareholding
18th Mar 202512:39 pmRNSDirector/PDMR Shareholding
26th Feb 20252:16 pmRNSHolding(s) in Company
26th Feb 20252:14 pmRNSHolding(s) in Company
7th Feb 20257:00 amRNSHalf-year Report
23rd Jan 202511:54 amRNSHolding(s) in Company
15th Jan 20257:00 amRNSTrading Statement
9th Jan 202511:32 amRNSHolding(s) in Company
9th Dec 20243:47 pmRNSDirector/PDMR Shareholding
7th Nov 20245:30 pmRNSDirector/PDMR Shareholding
6th Nov 20243:01 pmRNSResult of AGM
25th Oct 20242:04 pmRNSHolding(s) in Company
14th Oct 20247:00 amRNSTrading Statement
25th Sep 20249:38 amRNSNotice of AGM
17th Sep 20242:34 pmRNSAnnual Financial Report
16th Sep 20241:37 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.